Month: May 2017

Back in July, the FDA approved Adlyxin for diabetes type 2, and it is now available in pharmacies! When people think about injectable diabetes medications, the first thing that comes to mind tends to be insulin medications like Humalog (insulin lispro) or Lantus (insulin glargine). However, the FDA has been approving many new non-insulin products… Read More

Impaired sleep (insomnia) is a major complaint from patients in my practice, with huge personal and economic costs. When it comes to treatments for either difficulty going to sleep or staying asleep, looking for an easily reversible cause is the first step. One of the first places to look: many drugs may affect the quality… Read More

Osteoporosis affects one in four women ages 65 and older, making it more likely that you will break a bone in the hip, forearm, wrist, or spine. Osteoporosis occurs when you lose bone, don’t make enough bone, or a combination—and it can be caused by many things, including genetic makeup, diet, diseases and even some… Read More

On May 10th, 2017, the FDA issued a safety update on fluoroquinolone antibiotics, like Cipro and Levaquin, as part of an ongoing review. About a year ago, the FDA released findings that fluoroquinolone antibiotics can cause dangerous side effects involving the tendons, muscles, joints, nerves and central nervous system, and advised that use should be restricted in uncomplicated… Read More

Methicillin-resistant Staphylococcus aureus (MRSA) surgical site infections have been catastrophic for patients—they result in longer hospital stays and poorer outcomes. More than 80% of the time, infections result because of Staph aureus that we are carrying, in our nose or on our skin. For those of us who may be carriers of Staph aureus (it… Read More

Last week, GoodRx rolled out exclusive new savings on more than 40 brand-name prescriptions, and we also promised to pursue discounts for more drugs. Today, we’re happy to announce new Inside Rx discounts for 6 more brands: Colcrys (treats gout): 45% off retail price Uloric (treats gout): 16% off retail price Amitiza (treats constipation): 40% off retail… Read More

On April 21st, the FDA approved Renflexis (infliximab-abda), the second biosimilar to the popular medication Remicade, (infliximab) indicated for immune disorders. A biosimilar is like a generic medication in that it is less expensive than the brand name medication. However, the difference is that biosimilars are made out living cells, so they may be slightly different from their… Read More

Repetitive involuntary movements typically affecting the jaw, lips, tongue, arms or legs can be caused by tardive dyskinesia, a neurological disorder. Tardive dyskinesia is often seen as a side effect in patients taking antipsychotic medications used to treat certain mental illnesses. Previously, no medications were FDA approved to specifically treat tardive dyskinesia, making prevention key. This… Read More

Dry mouth (also known as xerostomia), is a significant problem faced by adults and unless due to a side effect from medication, there is no real cure. Often the reason for a case of dry mouth isn’t known, but some common causes include medications, head and neck radiation therapy for cancer, Sjogren’s syndrome, and type… Read More

At GoodRx, we’ve spent the last 6 years trying to do one thing—make prescriptions more affordable for Americans. We’re proud to say that we’ve helped millions of Americans save more than $2 billion, but that’s just a beginning—after all, Americans spend more than $400 billion on prescriptions each year! Prescriptions – especially brand-name drugs—remain too… Read More